Provided by Tiger Trade Technology Pte. Ltd.

Propanc Biopharma, Inc.

1.35
-0.8800-39.46%
Post-market: 1.34-0.0100-0.74%19:59 EDT
Volume:4.06M
Turnover:6.74M
Market Cap:4.73M
PE:-0.04
High:1.94
Open:1.93
Low:1.31
Close:2.23
52wk High:81.00
52wk Low:0.9500
Shares:3.50M
Float Shares:1.25M
Volume Ratio:0.21
T/O Rate:324.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-32.4560
EPS(LYR):-371.2241
ROE:-126.98%
ROA:-62.31%
PB:0.48
PE(LYR):0.00

Loading ...

Jul 17, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jul 14, 2026

Major Issues Report

Form 8-K - Current report
May 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 16, 2026

Correspondence

Form CORRESP - Correspondence
Apr 10, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 20, 2026

Correspondence

Form CORRESP - Correspondence
Feb 19, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 17, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 13, 2026

Correspondence

Form CORRESP - Correspondence
Feb 11, 2026

Correspondence

Form CORRESP - Correspondence
Feb 02, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 07, 2026

Major Issues Report

Form 8-K - Current report
Jan 07, 2026

Correspondence

Form CORRESP - Correspondence
Dec 30, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Oct 14, 2025

Major Issues Report

Form 8-K - Current report
Sep 29, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 19, 2025

Major Issues Report

Form 8-K - Current report